Meta Platforms, Inc. (META) vs Pfizer Inc. (PFE)
A side-by-side comparison of Meta Platforms, Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: META is classified in Communication Services; PFE is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
META
Meta Platforms, Inc.
$593.41Communication ServicesDelayed quote: Jul 28, 2026, 4:00 PM EDT
PFE
Pfizer Inc.
$25.25HealthcareDelayed quote: Jul 28, 2026, 4:02 PM EDT
Total return — META vs PFE
growth of $100 · dividends reinvested · last 14yMETA +1474.4%PFE +118.7%META compounded faster
Log scale — wide-divergence pair
META PFE
META vs PFE: by the numbers
- •META is the larger company ($1.51T vs $143.91B market cap).
- •PFE trades at the lower trailing earnings multiple (18.83 vs 21.60 P/E), one valuation lens rather than an overall verdict.
- •META converts more revenue to profit (32.84% vs 11.83% net margin).
- •META grew revenue faster over the past five years (17.89% vs 8.22% CAGR).
- •PFE pays the higher dividend yield (6.97% vs 0.35%).
Metrics side by side
Valuation
| Metric | META | PFE |
|---|---|---|
| P/E ratio | 21.60 | 18.83 |
| Forward P/E | 18.03 | 8.38 |
| P/S ratio | 7.08 | 2.23 |
| P/B ratio | 6.25 | 1.57 |
| PEG ratio | 1.16 | N/A |
| EV / EBITDA | 14.51 | 9.72 |
| FCF yield | 3.17% | 6.71% |
Profitability
| Metric | META | PFE |
|---|---|---|
| Gross margin | 81.94% | 69.35% |
| Operating margin | 41.21% | 23.45% |
| Net margin | 32.84% | 11.83% |
| ROE | 28.97% | 8.31% |
| ROIC | 17.95% | 8.84% |
Dividends
| Metric | META | PFE |
|---|---|---|
| Dividend yield | 0.35% | 6.97% |
| Payout ratio | 8.76% | 126.47% |
Growth (annualized)
| Metric | META | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 17.89% | 8.22% |
| EPS CAGR (5Y) | 18.60% | -3.78% |
| FCF CAGR (5Y) | 14.84% | -3.79% |
| Total return CAGR (5Y) | 10.03% | -5.21% |
Frequently asked
- Which has the lower trailing P/E, META or PFE?
- PFE has the lower trailing P/E: META trades at 21.60 and PFE at 18.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, META or PFE?
- Over the past five years, META grew revenue faster — META at a 17.89% CAGR versus PFE at 8.22%.
- Does META or PFE pay a bigger dividend?
- META yields 0.35% and PFE yields 6.97% based on trailing dividends and the latest price.
- Is META or PFE more profitable?
- META runs the higher net margin — META at 32.84% versus PFE at 11.83%.
- How have META and PFE total returns compared?
- Over the past 10 years, META delivered 17.02% and PFE delivered 1.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Meta Platforms P/E ratioPfizer P/E ratioMeta Platforms dividend yieldPfizer dividend yieldMeta Platforms ROEPfizer ROEMeta Platforms operating marginPfizer operating marginMeta Platforms revenue growthPfizer revenue growthMeta Platforms free cash flowPfizer free cash flow
Meta Platforms & Pfizer appear in these rankings
Highest Dividend Yield StocksFastest Revenue Growth StocksHighest ROE StocksHighest Operating Margin Stocks
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.